News
When even one tiny section of a person’s genetic code becomes mutated or modified, cells can begin to act out of ...
Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access.
UMass Chan Medical School has laid off or furloughed 200 employees, as the campus grapples with cuts to NIH research and ...
A team at CNIC has developed an innovative gene therapy to treat arrhythmogenic right ventricular cardiomyopathy type 5 ...
Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...
A major trial of a promising gene therapy for Duchenne muscular dystrophy has fallen short, but researchers say the lessons learned could pave the way for better, more effective treatments.
CROs can contribute to site collaboration by also identifying and supporting non-academic institutions capable of conducting ...
According to estimates by the World Federation of Hemophilia, nearly 80% of hemophilia cases in India remain undiagnosed, ...
From STAT’s Matthew Herper: Pfizer said this morning that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another medicine with ...
Genflow Biosciences Signs MSA with Heureka Labs, Launching AI-Powered Partnership in Gene Therapy Research ...
Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 ...
A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has developed an innovative gene-therapy strategy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results